Hancock Whitney Corp Gsk PLC Transaction History

Hancock Whitney Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$42.05 - $47.77 $31,453 - $35,731	-748 Reduced 12.88%	5,058 $220,000
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $17,580 - $20,862	437 Added 8.14%	5,806 $253,000
Q4 2021 Jan 25, 2022	SELL	$38.88 - $45.31 $45,411 - $52,922	-1,168 Reduced 17.87%	5,369 $237,000
Q3 2021 Nov 04, 2021	BUY	$38.79 - $43.16 $253,570 - $282,136	6,537 New	6,537 $250,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.